These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3441479)

  • 1. Kinetics of drug dissolution from tablets and capsules at high saturation.
    Kallay N; Senjković R
    Pharm Acta Helv; 1987; 62(12):337-40. PubMed ID: 3441479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug liberation from floating capsules in the rotating-flask solubility tester].
    Koch HP; Mertz M; Zinterhof G
    Pharmazie; 1987 May; 42(5):312-5. PubMed ID: 3671440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination and interpretation of in vitro solubility behavior of pharmaceutical agents. 2. The effect of surface tension of the dissolution medium on the liberation of drugs in commercial preparations (tablets, dragees)].
    Bornschein M; Eitz K; Voigt R
    Pharmazie; 1987 Feb; 42(2):83-6. PubMed ID: 3602064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A contribution to the kinetics of dissolution of some modern drugs.
    Csontos A; Rácz I; Gyarmati L
    Pharmazie; 1977; 32(8-9):498-500. PubMed ID: 594114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic].
    Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR
    Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Testing of drug release from film pellets with special consideration of the thickness of the polymer coating].
    Voigt R; Wunsch G
    Pharmazie; 1986 Feb; 41(2):114-7. PubMed ID: 3725849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S; Roa W; Löbenberg R
    Int J Pharm; 2007 Jan; 328(1):12-21. PubMed ID: 17084051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compendial dissolution tests: merits of sequential over standard inspection plans.
    Cho MJ; Pitman IH; Pernarowski M
    J Pharm Sci; 1973 Jan; 62(1):174-6. PubMed ID: 4682930
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liberation of the active ingredient from pharmaceutical microcapsules].
    Dévay A; Uderszky J; Rácz I
    Acta Pharm Hung; 1983 Jan; 53(1):28-35. PubMed ID: 6837317
    [No Abstract]   [Full Text] [Related]  

  • 14. Automation of nf method i-usp dissolution-rate test.
    Beyer WF; Smith EW
    J Pharm Sci; 1971 Oct; 60(10):1556-9. PubMed ID: 5129374
    [No Abstract]   [Full Text] [Related]  

  • 15. [Active ingredient release from solid drug forms--test methods, evaluation, influencing parameters].
    Knop K
    Pharm Unserer Zeit; 1999 Nov; 28(6):301-8. PubMed ID: 10614132
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
    Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
    Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants.
    Shah VP; Konecny JJ; Everett RL; McCullough B; Noorizadeh AC; Skelly JP
    Pharm Res; 1989 Jul; 6(7):612-8. PubMed ID: 2798311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissolution profiles for capsules and tablets using a magnetic basket dissolution apparatus.
    Shepherd RE; Price JC; Luzzi LA
    J Pharm Sci; 1972 Jul; 61(7):1152-6. PubMed ID: 5044819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.